Home/Filings/4/0001209191-17-048390
4//SEC Filing

Motahari Saeed 4

Accession 0001209191-17-048390

CIK 0001516479other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 2:42 PM ET

Size

5.1 KB

Accession

0001209191-17-048390

Insider Transaction Report

Form 4
Period: 2017-08-10
Motahari Saeed
DirectorPresident & CEO
Transactions
  • Purchase

    Common Stock

    2017-08-10$8.92/sh+5,500$49,05615,400 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.89 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeother

Related Parties

1
  • filerCIK 0001704399

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 2:42 PM ET
Size
5.1 KB